• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名使用阿哌沙班且植入左心耳封堵装置的患者发生心脏复律后装置相关血栓的病例报告

A case report of postcardioversion device-related thrombus in a patient with left atrial appendage occlusion device on apixaban.

作者信息

Ahmed Hasaan, Ismayl Mahmoud, Palicherla Anirudh, Heppler Miranda, Petraskova Terezia, Kousa Omar, Vargha Jalal

机构信息

Department of Medicine, Division of Internal Medicine.

Department of Cardiovascular Medicine, Mayo Clinic School of Medicine, Rochester, Minnesota, USA.

出版信息

Ann Med Surg (Lond). 2024 Jan 22;86(3):1729-1733. doi: 10.1097/MS9.0000000000001735. eCollection 2024 Mar.

DOI:10.1097/MS9.0000000000001735
PMID:38463065
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10923387/
Abstract

BACKGROUND

Current guidelines recommend proceeding with cardioversion, without the explicit need for preprocedural transesophageal echocardiography (TEE), in patients compliant with oral anticoagulation for at least 3 weeks. The relevance of these guidelines remains unclear in those undergoing repeat cardioversion.

CASE SUMMARY

A 66-year-old male with a history of atrial fibrillation (AF) and a left atrial appendage occlusion (LAAO) device, compliant with apixaban, presented with dyspnea and lightheadedness. He was cardioverted into sinus rhythm, 10 days before symptom onset, with TEE unremarkable at the time. An ECG revealed that the patient converted back into AF and a repeat cardioversion was scheduled. At the patient's request, a TEE was obtained, revealing a new 2 cm×1 cm thrombus in the left atrium above the WATCHMAN device. Cardioversion was canceled and the patient was hospitalized for AF management.

DISCUSSION

Cardioverted patients are at risk for thrombus formation due to atrial stunning, a transitory dysfunction of the atrial appendage and atrium, which occurs immediately after cardioversion and can persist for several weeks. The likelihood of a thrombus is further propagated by individual risk factors for stroke.

CONCLUSION

Anticoagulation does not eliminate the risk of thrombus formation in those with increased risk factors for stroke. Further studies are warranted to assess the need for routine TEE, after cardioversion, in those with stroke risk factors on anticoagulation or who have LAAO.

摘要

背景

当前指南建议,对于口服抗凝治疗至少3周的患者,进行心脏复律时无需明确进行术前经食管超声心动图(TEE)检查。对于接受重复心脏复律的患者,这些指南的相关性仍不明确。

病例摘要

一名66岁男性,有房颤(AF)病史且植入了左心耳封堵(LAAO)装置,服用阿哌沙班,出现呼吸困难和头晕。症状出现前10天,他被转复为窦性心律,当时TEE检查未见异常。心电图显示患者又转为房颤,计划进行重复心脏复律。应患者要求,进行了TEE检查,结果显示在WATCHMAN装置上方的左心房有一个新的2cm×1cm血栓。心脏复律取消,患者因房颤管理住院。

讨论

心脏复律后的患者因心房顿抑有血栓形成风险,心房顿抑是心房附件和心房的短暂性功能障碍,在心脏复律后立即发生,可持续数周。中风的个体危险因素会进一步增加血栓形成的可能性。

结论

抗凝并不能消除中风风险增加患者的血栓形成风险。有必要进行进一步研究,以评估在接受抗凝治疗或植入LAAO且有中风危险因素的患者心脏复律后进行常规TEE检查的必要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0a8/10923387/b50a35ddcf30/ms9-86-1729-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0a8/10923387/83edd9507c50/ms9-86-1729-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0a8/10923387/c665bcd74f28/ms9-86-1729-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0a8/10923387/b50a35ddcf30/ms9-86-1729-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0a8/10923387/83edd9507c50/ms9-86-1729-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0a8/10923387/c665bcd74f28/ms9-86-1729-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0a8/10923387/b50a35ddcf30/ms9-86-1729-g003.jpg

相似文献

1
A case report of postcardioversion device-related thrombus in a patient with left atrial appendage occlusion device on apixaban.一名使用阿哌沙班且植入左心耳封堵装置的患者发生心脏复律后装置相关血栓的病例报告
Ann Med Surg (Lond). 2024 Jan 22;86(3):1729-1733. doi: 10.1097/MS9.0000000000001735. eCollection 2024 Mar.
2
[Transesophageal echocardiography in patients with atrial fibrillation, candidates for cardioversion: usefulness and limitations].[经食管超声心动图在房颤患者(心脏复律候选者)中的应用:实用性与局限性]
G Ital Cardiol. 1995 May;25(5):543-52.
3
Transesophageal Echocardiogram Before Cardioversion in Atrial Fibrillation Patients.心房颤动患者心脏复律前的经食管超声心动图检查
Cureus. 2023 May 30;15(5):e39702. doi: 10.7759/cureus.39702. eCollection 2023 May.
4
Incidence, Characteristics, and Clinical Course of Device-Related Thrombus After Watchman Left Atrial Appendage Occlusion Device Implantation in Atrial Fibrillation Patients.房颤患者 Watchman 左心耳封堵装置植入术后与器械相关的血栓形成的发生率、特征和临床过程。
JACC Clin Electrophysiol. 2017 Dec 11;3(12):1380-1386. doi: 10.1016/j.jacep.2017.05.006. Epub 2017 Aug 2.
5
Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).心房颤动的抗栓治疗:美国胸科医师学会循证临床实践指南(第8版)
Chest. 2008 Jun;133(6 Suppl):546S-592S. doi: 10.1378/chest.08-0678.
6
Direct Current Cardioversion of Atrial Fibrillation in Patients With Left Atrial Appendage Occlusion Devices.左心耳封堵装置患者的直流电复律转复心房颤动。
J Am Coll Cardiol. 2019 Nov 5;74(18):2267-2274. doi: 10.1016/j.jacc.2019.08.1045.
7
Late-onset left atrial appendage occlusion device-related thrombus attributed to mitral bioprosthetic stenosis: a case report.迟发性左心耳封堵装置相关血栓归因于二尖瓣生物瓣狭窄:一例报告
Eur Heart J Case Rep. 2024 Aug 23;8(9):ytae438. doi: 10.1093/ehjcr/ytae438. eCollection 2024 Sep.
8
A new therapeutic strategy for electrical cardioversion of atrial fibrillation.一种用于心房颤动电复律的新治疗策略。
Ital Heart J. 2001 Nov;2(11):831-40.
9
Post-cardioversion atrial stunning - Not to be forgotten.心脏复律后心房顿抑——不容忽视。
Echocardiography. 2023 Mar;40(3):266-270. doi: 10.1111/echo.15517. Epub 2023 Jan 3.
10
Direct current cardioversion practices following percutaneous left atrial appendage closure.经皮左心耳封堵术后直流电复律的实践。
J Cardiovasc Electrophysiol. 2023 Aug;34(8):1698-1705. doi: 10.1111/jce.15999. Epub 2023 Jul 26.

本文引用的文献

1
The SCARE 2023 guideline: updating consensus Surgical CAse REport (SCARE) guidelines.SCARE 2023 指南:更新共识外科病例报告(SCARE)指南。
Int J Surg. 2023 May 1;109(5):1136-1140. doi: 10.1097/JS9.0000000000000373.
2
Absence of significant myocardial injury following elective direct current cardioversion for atrial fibrillation.心房颤动择期直流电复律后无明显心肌损伤。
Heart Rhythm O2. 2022 Dec 21;4(3):180-186. doi: 10.1016/j.hroo.2022.12.004. eCollection 2023 Mar.
3
Prevalence of Left Atrial Thrombus in Anticoagulated Patients With Atrial Fibrillation.
抗凝治疗的心房颤动患者左心房血栓的发生率。
J Am Coll Cardiol. 2021 Jun 15;77(23):2875-2886. doi: 10.1016/j.jacc.2021.04.036.
4
Acute pathophysiological myocardial changes following intra-cardiac electrical shocks using a proteomic approach in a sheep model.采用蛋白质组学方法研究羊模型中心内电休克后急性病理生理心肌变化。
Sci Rep. 2020 Nov 20;10(1):20252. doi: 10.1038/s41598-020-77346-x.
5
Direct Current Cardioversion of Atrial Fibrillation in Patients With Left Atrial Appendage Occlusion Devices.左心耳封堵装置患者的直流电复律转复心房颤动。
J Am Coll Cardiol. 2019 Nov 5;74(18):2267-2274. doi: 10.1016/j.jacc.2019.08.1045.
6
Device-Related Thrombus After Left Atrial Appendage Closure: Incidence, Predictors, and Outcomes.左心耳封堵术后与器械相关的血栓:发生率、预测因素和结局。
Circulation. 2018 Aug 28;138(9):874-885. doi: 10.1161/CIRCULATIONAHA.118.035090.
7
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.2016年欧洲心脏病学会(ESC)与欧洲心胸外科学会(EACTS)合作制定的心房颤动管理指南。
Eur Heart J. 2016 Oct 7;37(38):2893-2962. doi: 10.1093/eurheartj/ehw210. Epub 2016 Aug 27.
8
Transesophageal echocardiography-guided cardioversion after cardiac operations.心脏手术后经食管超声心动图引导下的心脏复律
Ann Thorac Surg. 2014 Oct;98(4):1325-30. doi: 10.1016/j.athoracsur.2014.06.029. Epub 2014 Aug 22.
9
Prevention of thromboembolism after cardioversion of recent-onset atrial fibrillation: brief is not always safe.近期发作的心房颤动复律后血栓栓塞的预防:短暂并不总是安全的。
J Am Coll Cardiol. 2013 Sep 24;62(13):1193-4. doi: 10.1016/j.jacc.2013.06.019. Epub 2013 Jul 10.
10
Transesophageal echocardiography before and during direct current cardioversion of atrial fibrillation: evidence for "atrial stunning" as a mechanism of thromboembolic complications.心房颤动直流电复律前后的经食管超声心动图检查:“心房顿抑”作为血栓栓塞并发症机制的证据
J Am Coll Cardiol. 1994 Feb;23(2):307-16. doi: 10.1016/0735-1097(94)90412-x.